Endocrine System Channel
Related Channels

Precautions and Warnings with Linagliptin/Metformin

If your healthcare provider is recommending diabetes treatment with linagliptin/metformin, he or she will first ask you about your medical history and any medications or supplements you are taking. This information is important to help determine whether this medication is appropriate for you. Safety precautions associated with linagliptin/metformin also include warnings for people who have certain risk factors for developing lactic acidosis.

What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to taking linagliptin/metformin (Jentadueto™) if you have:
  • Kidney disease, such as kidney failure (renal failure)
  • Liver disease, such as liver failure, hepatitis, or cirrhosis
  • An alcohol problem
  • An upcoming radiology procedure that will require the use of contrast dye
  • Pernicious anemia
  • Type 1 diabetes
  • Diabetic ketoacidosis
  • Any allergies, including to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
You should also tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.

Specific Linagliptin/Metformin Precautions and Warnings

Some warnings and precautions to be aware of prior to taking this medication include the following:
Drinking alcohol can also increase your risk for lactic acidosis. Drinking large amounts of alcohol on a regular basis or drinking a large amount at once (binge drinking) should be avoided while taking linagliptin/metformin (see Metformin and Alcohol).
  • Because liver disease, including liver failure and cirrhosis, can increase your risk for lactic acidosis, you should not take linagliptin/metformin if your liver is not functioning normally.
  • Your kidney function needs to be monitored while you are taking linagliptin/metformin. This means that you should have blood tests to check your kidneys before you start this medicine, and then at least once every year. If your kidney function is very poor, you should not take linagliptin/metformin, as it can increase the risk for lactic acidosis.
  • Taking linagliptin/metformin and contrast dye at the same time can increase your risk for kidney damage. Contrast dye is used for certain radiology procedures, including some x-rays, computed tomography (CT) scans, and heart catheterizations (see Metformin and Contrast Medium). Also, linagliptin/metformin should be stopped temporarily for most major surgeries and restarted when you are eating normally again.
  • Fever, infections, injury, or surgery can increase your blood sugar levels temporarily, even in people who have well-controlled diabetes. Linagliptin/metformin may not be sufficient to treat your diabetes during these times, and you may need to use insulin. Contact your healthcare provider if you have a fever, infection, injury, or an upcoming surgery. Also, make sure you know the symptoms of high blood sugar and how to check your blood sugar levels.
  • Let your healthcare provider know if you have an illness that causes severe vomiting, diarrhea, or fever, or if you drink a much lower amount of liquid than normal. These conditions can lead to severe dehydration (loss of water in your body). You may need to stop taking linagliptin/metformin for a short time.
  • Linagliptin/metformin can decrease your levels of vitamin B12. Your healthcare provider should monitor your vitamin B12 levels, especially if you have a vitamin B12 deficiency like pernicious anemia.
  • In rare cases, linagliptin/metformin can cause low blood sugar levels (hypoglycemia), usually when it is combined with other diabetes medications. This is more common in elderly people; those who have problems with their adrenal gland, pituitary gland, liver, or kidneys; and people who are fasting before surgery or have finished prolonged exercise. Low blood sugar symptoms may include:
    • Irritability
    • Trembling
    • Cold sweats
    • Blurry vision.
  • Linagliptin/metformin is a pregnancy Category B medication. This means that it is probably safe for use in pregnant women, although the full risks are currently unknown. Talk to your healthcare provider before taking this medication during pregnancy (see Jentadueto and Pregnancy).
  • At least one of the active ingredients in linagliptin/metformin passes through breast milk. Therefore, if you are breastfeeding or plan to start, talk with your healthcare provider about using this drug (see Jentadueto and Breastfeeding).
Type 2 Diabetes: Fact or Fiction

Linagliptin/Metformin Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.